Dezin Counsulting Private Limited

New Business & New Therapy Launch in Pharma Market

New Business & New Therapy Launch in Pharma Market

We help the launching of new businesses as well as a new therapy segment launch from the basic market research up to turning it into a success in the market. These activities include providing reports about the market segments, external data, product selection, regulatory requirements, contract manufacturing (if needed), HR Services, setting up a distribution network, planning & preparing of promotional material, launch strategy, target customer lists, promotional plan and payment collection system.

Entering into a new business or new therapy segment needs the expertise in various areas of Pharma business in India. We have a highly experienced and result-oriented team of professionals to assist you every step of the way. Our team can ensure that your investment is done in the right place and you get the best ROI on your investments.

Entering into a new business or new therapy segment needs the expertise in various areas of Pharma business in India. We have a highly experienced and result-oriented team of professionals to assist you every step of the way. Our team can ensure that your investment is done in the right place and you get the best ROI on your investments.

In the current Pharma market, certain things which are very critical right now are – quality of the products, the efficiency of the team, and cost-effectiveness of the whole operation. In this environment, it is very important to know where to have a fixed cost and which services should be outsourced.

Dezin has a very flexible approach to assist you in whichever part of the operation you want to outsource and where you want consulting support and which area you want to operate yourself. Dezin is an ideal Indian partner for multinational companies (MNCs) operating in India. Dezin is also recommended for companies who want to expand here or want to enter the Indian pharma market. We are an equally good potential partner to Indian companies who want to expand operations or want to work upon efficiency or cost-effectiveness part of operations.

India is the home of over 15% of the world population and has a huge growth scope in the pharma market. Indian pharma market is a recession-free market for at least the next 3 decades. Until now, India’s 50% market was dominated by the acute segment but growth in chronic/sub chronic segments are much faster than in the acute segments. With the changing socio-economic pattern in India, lifestyle diseases market is all set to grow much faster in the upcoming years. India is shifting from a non-regulated market to a regulated market. These changes make it the right time to enter and/or expand in the Indian pharma market right now.